Sugammadex: Good drugs do not replace good clinical practice [1]

Anesthesia and Analgesia

Volumn 105, Issue 5, 2007, Pages 1506-

  Hemmerling, Thomas M ^a   Geldner, Goetz ^b  

^a MCGILL UNIVERSITY   (Canada)

^b KLINIKUM LUDWIGSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DESFLURANE; GLYCOPYRRONIUM BROMIDE; NEOSTIGMINE; OPIATE; REMIFENTANIL; ROCURONIUM; SEVOFLURANE; SUGAMMADEX;

GOOD CLINICAL PRACTICE; LETTER; LOCAL ANESTHESIA; METHODOLOGY; NEUROMUSCULAR BLOCKING; PATIENT MONITORING; PRIORITY JOURNAL; REGIONAL ANESTHESIA; RISK BENEFIT ANALYSIS;

EID: 37349048900     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000286076.42172.87     Document Type: Letter

References (5)

1. Miller RD. Sugammadex: an opportunity to change the practice of anesthesiology? Anesth Analg 2007;104:477-8
2. Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg 2007;104:575-81
3. Eriksson LI. Evidence-based practice and neuromuscular monitoring: it's time for routine quantitative assessment. Anesthesiology 2003;98:1037-9
4. Hemmerling TM, Le N. Brief review: neuromuscular monitoring: an update for the clinician. Can J Anaesth 2007;54:58-72
5. Eleveld DJ, Kuizenga K, Proost JH, Wierda JM. A temporary decrease in twitch response during reversal of rocuronium-induced muscle relaxation with a small dose of sugammadex. Anesth Analg 2007;104:582-4